Immucell (ICCC) Accumulated Expenses (2010 - 2014)
Immucell (ICCC) recorded Accumulated Expenses of $367,233 in Q3 2014, up 73.2% from $212,082 a year earlier but down 19.9% from the prior quarter.
Powered by 
Analysis
Immucell (ICCC) Accumulated Expenses (2010 - 2014) Analysis & Trends
At the end of FY2013, Immucell reported Accumulated Expenses of $293,076, up 14.7% from FY2012.
- Annual Accumulated Expenses has a three-year compound annual growth rate of -7.6% (FY2010 to FY2013).
- Across earlier years, Accumulated Expenses came in at $255,568 in FY2012 (-15.9%), $303,900 in FY2011 (-18.3%) and $372,052 in FY2010.
- Quarterly Accumulated Expenses has ranged from $205,282 in Q3 2012 to $652,882 in Q2 2011 over the past five years.
- On a year-over-year basis, Accumulated Expenses has increased for six consecutive quarters, with growth averaging 22.4% over the last eight quarters.
- Peak year-over-year performance for Accumulated Expenses in the last five years was growth of 73.2% in Q3 2014, against a decline of 64.8% in Q2 2012 at the low end.
- Per Business Quant, the preceding three quarters came in at $458,615 (Q2 2014), $282,988 (Q1 2014) and $293,076 (Q4 2013).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Immucell | 95.91 Mn | 73.35 Mn | 2.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2014 | 367,233.00 |
| Jun 30, 2014 | 458,615.00 |
| Mar 31, 2014 | 282,988.00 |
| Dec 31, 2013 | 293,076.00 |
| Sep 30, 2013 | 212,082.00 |
| Jun 30, 2013 | 285,776.00 |
| Mar 31, 2013 | 232,599.00 |
| Dec 31, 2012 | 255,568.00 |
| Sep 30, 2012 | 205,282.00 |
| Jun 30, 2012 | 229,520.00 |
| Mar 31, 2012 | 239,005.00 |
| Dec 31, 2011 | 303,900.00 |
| Sep 30, 2011 | 331,398.00 |
| Jun 30, 2011 | 652,882.00 |
| Dec 31, 2010 | 372,052.00 |
API Access
Immucell Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ICCC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "ICCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ICCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();